Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sex differences associated with adverse drug reactions resulting in hospital admissions
Linda C. Hendriksen, Paul D. van der Linden, A. L. M. Lagro-Janssen, et al.
Biology of Sex Differences (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Interactions between Gender and Sepsis—Implications for the Future
Inès Lakbar, Sharon Einav, Nathalie Lalevée, et al.
Microorganisms (2023) Vol. 11, Iss. 3, pp. 746-746
Open Access | Times Cited: 35
Quality control and analytic best practices for testing genetic models of sex differences in large populations
Ekaterina Khramtsova, Melissa A. Wilson, Joanna Martin, et al.
Cell (2023) Vol. 186, Iss. 10, pp. 2044-2061
Open Access | Times Cited: 26
Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13302-13302
Open Access | Times Cited: 44
Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review
Mirabela Romanescu, Valentina Buda, Adelina Lombrea, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 907-907
Open Access | Times Cited: 33
Sex-Specific Differences in Lipoprotein Production and Clearance
Donna Conlon, Francine K. Welty, Gissette Reyes‐Soffer, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 9, pp. 1617-1625
Closed Access | Times Cited: 16
Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with thiazide diuretics for decompensated heart failure) trial
Alicia Conde‐Martel, Joan Carles Trullàs, José Luís Morales‐Rull, et al.
Revista Clínica Española (English Edition) (2024) Vol. 224, Iss. 2, pp. 67-76
Closed Access | Times Cited: 5
Blood Pressure and Stroke: A Review of Sex- and Ethnic/Racial-Specific Attributes to the Epidemiology, Pathophysiology, and Management of Raised Blood Pressure
Xia Wang, Cheryl Carcel, Mark Woodward, et al.
Stroke (2022) Vol. 53, Iss. 4, pp. 1114-1133
Open Access | Times Cited: 20
Women on diuretics have a higher risk of hospital admission because of hyponatremia than men
Linda C. Hendriksen, Paul D. van der Linden, Ron M. C. Herings, et al.
Pharmacoepidemiology and Drug Safety (2023) Vol. 32, Iss. 6, pp. 635-642
Open Access | Times Cited: 7
Diferencias en función del sexo en las características clínicas y resultados del ensayo clínico CLOROTIC (combinación de diuréticos de asa con tiazidas en la insuficiencia cardiaca descompensada)
Alicia Conde‐Martel, Joan Carles Trullàs, José Luís Morales‐Rull, et al.
Revista Clínica Española (2024) Vol. 224, Iss. 2, pp. 67-76
Closed Access | Times Cited: 2
The effects of diuretic deprescribing in adult patients: A systematic review to inform an evidence‐based diuretic deprescribing guideline
Eveline P. van Poelgeest, Luca Paoletti, Serdar Özkök, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 2
Comparative Post‐Marketing Surveillance of Memantine and Cholinesterase Inhibitors: Cardiovascular Adverse Events With a Focus on Sex Differences Using the FDA Adverse Event Reporting System Database
Zinnet Şevval Aksoyalp, Dilara Nemutlu Samur
International Journal of Geriatric Psychiatry (2024) Vol. 39, Iss. 11
Closed Access | Times Cited: 2
Sex differences in hypertension. Do we need a sex-specific guideline?
Renata Cífková, L. M. Strilchuk
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
Jordi Barrachina, César Margarit, Javier Muriel, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2468-2468
Open Access | Times Cited: 8
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
Kenneth L. McCall, Bennett Doughty, Brian J. Piper, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 2, pp. 515-521
Closed Access | Times Cited: 1
Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: A scoping review
Swetha R. Reghunath, Muhammed Rashid, Viji Pulikkel Chandran, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 17, Iss. 7, pp. 102790-102790
Closed Access | Times Cited: 4
Risk of Hospitalization for Adverse Drug Events in Women and Men: A Post Hoc Analysis of an Active Pharmacovigilance Study in Italian Emergency Departments
Giada Crescioli, Ennio Boscia, Alessandra Bettiol, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 678-678
Open Access | Times Cited: 9
Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database
Zhiming Jiao, Ganyi Wang, Zhanchun Feng, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 6
Sex differences in adverse drug reactions: Are women more impacted?
Clémence Lacroix, Anaïs Maurier, Bérenger Largeau, et al.
Therapies (2022) Vol. 78, Iss. 2, pp. 175-188
Open Access | Times Cited: 6
The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
Valerio Liguori, Mario Gaio, Alessia Zinzi, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2538-2538
Open Access | Times Cited: 3
Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors
Emiel Leegwater, Annette C. Westgeest, Emile F. Schippers, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 6, pp. 2938-2945
Open Access | Times Cited: 5
Adverse drug reactions
Matthew J. Robinson, Muataz Amare
Anaesthesia & intensive care medicine (2023) Vol. 24, Iss. 3, pp. 210-214
Closed Access | Times Cited: 2
Computational screen for sex-specific drug effects in a cardiac fibroblast signaling network model
Kelsey Watts, W. Stephen Nichols, William J. Richardson
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Risk of Hospitalization for Adverse Drug Events in Women and Men: A Post-Hoc Analysis of an Active Pharmacovigilance Study in Italian Emergency Departments
Giada Crescioli, Ennio Boscia, Alessandra Bettiol, et al.
(2021)
Open Access | Times Cited: 5
Neuronal toxicity of Monoclonal antibodies (mAbs): An analysis of post marketing reports from FDA Adverse Event Reporting System (FAERS) safety database
Nitin Kumar, Vivekanandan Kalaiselvan, Mandeep Kumar Arora
Research Square (Research Square) (2024)
Open Access
Genetic Variability of CYP4F2, CYP2D6, CYP2E1, and ACE in the Chinese Yi Population
Jinping Guo, Wenqian Zhou, Xiaoya Ma, et al.
Biochemical Genetics (2024)
Closed Access
Page 1 - Next Page

Scroll to top